Tavexia Lifecare Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 4,18,318 shares,. Its Average Traded Price (ATP) is ₹1.06, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 63121 @ ₹1.07.
Tavexia Lifecare has an upper circuit limit of ₹1.12 and a lower circuit limit of ₹1.02. The total value traded stands at ₹4.43 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Tavexia Lifecare also offers a dividend yield of 0%.
Tavexia Lifecare Share Price Chart
Tavexia Lifecare Share Key Metrics
Volume
4.18 L
Market Cap
41.05 CR
LTQ@LTP
63121@1.07
ATP
1.06
Var Margin
100 %
Circuit Range
1.02-1.12
Delivery %
100 %
Value
4.43 L
ASM/GSM
No
Market Lot
1
Tavexia Lifecare Resistance and Support
Pivot 1.07
Resistance
First Resistance
1.09
Second Resistance
1.1
Third Resistance
1.12
Support
First Support
1.06
Second Support
1.04
Third Support
1.03
Tavexia Lifecare Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Tavexia Lifecare Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-04 | A.G.M. |
| 2026-08-04 | Quarterly Results |
| 2026-06-30 | Others |
| 2026-06-04 | Audited Results |
| 2026-05-30 | Audited Results |
| 2026-02-19 | Quarterly Results |
| 2026-02-16 | Quarterly Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-25 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-03 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-06-21 | Others |
| 2025-05-05 | Audited Results & Rights issue |
| 2025-04-30 | Audited Results & Rights issue |
| 2025-04-23 | Others |
| 2025-02-11 | Quarterly Results |
| 2025-01-25 | Others |
| 2025-01-18 | Allotment of Bonus shares |
| 2024-12-02 | Bonus issue |
| 2024-11-12 | Quarterly Results |
| 2024-08-30 | Stock Split & A.G.M. |
| 2024-08-16 | Rights issue |
| 2024-08-05 | Quarterly Results |
| 2023-10-11 | Others |
| Bonus Date | Record Date | |
|---|---|---|
| 2024-12-02 | 2025-01-17 | View More |
| Rights Date | Ratio | |
|---|---|---|
| 2025-05-09 | 5:2 | View More |
| Split Ratio | Split Date | |
|---|---|---|
| 5:1 | 2024-10-25 | View More |
Tavexia Lifecare News
Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sattva Sukun Lifecare's promoter group, Roshan Dealmark Private Limited, disposed of 14 lakh equity shares, resulting in a 0.36% reduction in their total shareholding to 5.66%. The transaction was conducted through an on-market trade on September 7, 2026.
Sep 08 2026 10:56:22
Tavexia Lifecare Ltd - 539519 - Proposal For Acquisition Of Up To 60% Equity Share Capital Of Meyonex Pharmaceuticals Limited,
Sattva Sukun Lifecare's board approved exploring a potential acquisition of up to 60% equity in Meyonex Pharmaceuticals Limited. The board authorized directors to conduct due diligence and negotiations. Additionally, statutory auditor M/s SSRV & Associates resigned, and M/s Devam & Associates LLP was appointed in its place.
Sep 07 2026 19:30:26
Tavexia Lifecare Ltd - 539519 - Appointment Of Director
Sattva Sukun Lifecare's board authorized preliminary evaluation and due diligence for a proposed acquisition of up to 60% equity share capital in Meyonex Pharmaceuticals Limited. This move signals a potential strategic diversification for the company into the pharmaceutical sector.
Sep 07 2026 19:28:04
Tavexia Lifecare Ltd - 539519 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Sattva Sukun's board accepted the resignation of its statutory auditors M/s SSRV & Associates, effective September 7, 2026. M/s DEVAM & Associates LLP has been appointed for a five-year term, subject to shareholder approval at the upcoming AGM, filling the casual vacancy.
Sep 07 2026 19:24:31
Tavexia Lifecare Ltd - 539519 - Board Meeting Outcome for Outcome Of Board Meeting
Tavexia Lifecare Board approved the preliminary evaluation for acquiring up to 60% equity share capital of Meyonex Pharmaceuticals Ltd, an unlisted public company. Directors Mr. Chirag Deepak Dedhia and Mr. Sachin Bhanubhai Manseta are authorized to conduct due diligence and negotiations for this strategic expansion.
Sep 07 2026 19:20:34
Tavexia Lifecare Ltd - 539519 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Tavexia Lifecare Limited's statutory auditor, M/s. SSRV and Associates, has resigned with immediate effect from September 7, 2026. The auditor cited preoccupation with other professional commitments as the reason for their mid-term resignation. The company reported no concerns requiring communication to the Audit Committee.
Sep 07 2026 18:17:56
Tavexia Lifecare Ltd - 539519 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sattva Sukun Lifecare's promoter group, Roshan Dealmark Private Limited, disposed of 1.4 million equity shares through an on-market transaction on September 03, 2026. This sale reduced their shareholding in the company by 0.36%.
Sep 07 2026 11:31:09
Tavexia Lifecare Ltd - 539519 - Board Meeting Intimation for Intimation Regarding Adjournment Of Board Meeting
Sattva Sukun Lifecare's Board of Directors meeting, previously set for September 4, 2026, has been adjourned due to unavoidable circumstances. The meeting is now rescheduled for September 7, 2026, with the same agenda items.
Sep 04 2026 20:50:17
Tavexia Lifecare Ltd - 539519 - Board Meeting Intimation for Meeting Of Board Of Directors Of Tavexia Lifecare Ltd Is Schedule To Be Held On Friday, 04Th September 2026 .
Sattva Sukun Lifecare's Board of Directors will meet on September 4, 2026. The agenda includes considering and approving the annual financial results for the fiscal year ended March 31, 2026, and other corporate reports.
Sep 01 2026 16:42:52
Tavexia Lifecare Ltd - 539519 - Announcement Under Regulation 30
Tavexia Lifecare has expanded its business by entering the pharmaceutical sector as a new growth vertical. This move aims to diversify the company's revenue base and leverage opportunities in India's growing pharmaceutical market.
Aug 26 2026 08:35:20
Tavexia Lifecare Management
| Name | Position |
|---|---|
| Poonam Rani | Company Secretary & Compliance Officer |
| Mit Tarunkumar Brahmbhatt | Managing Director |
Tavexia Lifecare Similar Stocks
Tavexia Lifecare FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in TAVEXIA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC